These genes include TP63 for bladder cancer, FGFR2 and MAP3K1 for breast cancer, HNF1B for ovarian cancer, KLK3 for prostate cancer, and CDKN2A for skin cancer. This evidence concerns the gene CDKN2A and ovarian carcinoma.